Newcleo Opens Employee Stock Option Window Ahead of SPAC Merger, Reveals Key Terms
NHIC is trading near its 52-week low of $9.86 (11% above the low) on light trading volume (0.1× avg).
Summary
Newcleo's employee presentation reveals a stock option exercise window, a trading suspension since July 1, a 1-for-481 reverse split, and a 10% earn-out — key details for the pending SPAC merger with NewHold Investment Corp. III.
Key Events · M&A and Partnerships · NHIC
-
Employee Stock Option Window Opens
Newcleo opened a window from July 6-10, 2026 for employees to exercise vested stock options, with detailed tax implications for French residents.
-
Trading Suspension and Lock-Up
Newcleo shares have been suspended from trading since July 1, 2026, and a 180-day lock-up post-IPO will apply to shares from pre-IPO options.
-
Reverse Stock Split Details
A 1-for-481 reverse stock split will adjust the share value to USD10, with no impact on overall holdings value.
-
Earn-Out for Option Holders
Stock option holders at closing will receive an additional 10% in options, vesting if the stock price exceeds USD15 and USD18 over 20 of 30 consecutive days within 5 years.
Analysis · NHIC · Real Estate & Construction
Newcleo, the target in the pending $2.4 billion SPAC merger with NewHold Investment Corp. III, has opened a stock option exercise window for employees from July 6-10, 2026. The presentation discloses that trading in Newcleo shares has been suspended since July 1, 2026, and that a 180-day lock-up will apply post-IPO for shares from pre-IPO options. It also details a 1-for-481 reverse stock split to set the share value at USD10, and an earn-out of additional 10% stock options for holders at closing, with price triggers at USD15 and USD18. These specifics on capital restructuring and insider liquidity constraints are material for SPAC shareholders evaluating the merger's impact on dilution and post-close trading dynamics.
At the time of this filing, NHIC was trading at $10.92 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $301.5M. The 52-week trading range was $9.86 to $11.60. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.